SBIR PHASE I - WEARABLE BIOSENSOR THAT QUANTIFIES BLOOD ALCOHOL CONCENTRATION IN REAL TIME

SBIR 第一阶段——实时量化血液酒精浓度的可穿戴生物传感器

• 批准号: 10037810
• 负责人: ERIK METALLA
• 金额: $ 49.87万
• 依托单位: SUGPIAT DEFENSE, LLC
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-25 至 2020-06-24
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10037810
• 关键词: Alcohol consumption; Algorithms; Biological; Biosensor; Blood Tests; Blood alcohol level measurement; Breathalyzer Tests; Cellular Phone; Clinical Research; Contracts; Devices; Effectiveness; Gait; Individual; Measurement; Measures; Methods; Modeling; Motor Vehicles; Pharmaceutical Preparations; Phase; Preventive measure; Reporting; Research; Risk Factors; Shoes; Small Business Innovation Research Grant; Technology; Testing; Time; diabetic; response; smart watch; wearable technology

Current methods available to measure use of alcohol and the biological response of the drug in individuals are mostly limited to cumbersome breathalyzer or blood tests. A current need exists to effectively and non-invasively measure blood alcohol concentration (BAC) in real-time as a preventative measure toward restraining individuals from operating motor vehicles or other heavy machinery with BACs that would present a danger to themselves or others. As wearable technologies such as smartphones and smart watches have become staple items over the past decade, it is believed that such technology would be readily accepted and be less cumbersome and more timely than current breathalyzer or blood tests in measuring Blood Alcohol Concentration (BAC).

目前可用于测量酒精使用和药物在个体中的生物反应的方法大多限于繁琐的呼吸测醉器或血液测试。 当前需要实时有效且非侵入性地测量血液酒精浓度（BAC），作为防止个体操作具有BAC的机动车辆或其他重型机械的预防措施，所述BAC会对他们自己或他人造成危险。 由于智能手机和智能手表等可穿戴技术在过去十年中已成为主要产品，因此相信这种技术将易于接受，并且在测量血液酒精浓度（BAC）方面比当前的呼气测醉器或血液测试更不繁琐且更及时。